Physician Assistant · Gulf Breeze, FL
NPI
1144248824
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1200 Gulf Breeze Pkwy Ste A
Gulf Breeze, FL, 32561
Phone (800) 243-7546
Groups this clinician bills Medicare through
Medicare paid, 2024
$257K
7,030 services
Medicare patients, 2024
1,137
Average age 76
Drug cost, 2024
$923K
1,870 prescriptions
Company payments, 2025
$1,091
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Randy G Banks was code 17003 (destruction skin lesion), 2,734 times for 437 patients. In total Randy G Banks billed 7,030 services in 52 codes, and Medicare paid $257K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,734 | 437 | $4.11 | $11K |
| 99213 Office E&M - Established | Office | 910 | 662 | $53.42 | $49K |
| 17000 Destruction Skin Lesion | Office | 688 | 548 | $30.76 | $21K |
| 11102 Skin Biopsy | Office | 605 | 527 | $57.13 | $35K |
| 11103 Skin Biopsy | Office | 393 | 225 | $32.46 | $13K |
| 17004 Destruction Skin Lesion | Office | 279 | 201 | $104.29 | $29K |
| 99212 Office E&M - Established | Office | 242 | 220 | $34.90 | $8,445 |
| 99214 Office E&M - Established | Office | 221 | 196 | $76.42 | $17K |
| 17110 Destruction Skin Lesion | Office | 204 | 184 | $67.38 | $14K |
| 99203 Office E&M - New | Office | 179 | 179 | $64.44 | $12K |
| 17262 Destruction Skin Lesion | Office | 86 | 70 | $101.72 | $8,748 |
| 12032 Wound Repair - All Levels | Office | 55 | 50 | $205.21 | $11K |
| 11104 Skin Biopsy | Office | 52 | 48 | $73.92 | $3,844 |
| 11602 Skin Lesion Excision | Office | 42 | 40 | $83.09 | $3,490 |
| 69100 Other Organ Systems | Office | 41 | 40 | $40.57 | $1,663 |
By year: 2022 $15K for 369 services; 2023 $142K for 3,822 services; 2024 $257K for 7,030 services.
Medicare prescription drug claims, 2024
In 2024, the drug Randy G Banks prescribed most often to Medicare patients was Fluorouracil, with 334 prescriptions and refills. In total Randy G Banks wrote 1,870 Medicare prescriptions that cost $923K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluorouracil Generic | 334 | 340 | 302 | $26K |
| Ketoconazole Generic | 293 | 309 | 174 | $7,201 |
| Triamcinolone Acetonide Generic | 263 | 314 | 194 | $3,479 |
| Clobetasol Propionate Generic | 127 | 135 | 67 | $6,100 |
| Doxycycline Monohydrate Generic | 120 | 131 | 67 | $2,590 |
| Montelukast Sodium Generic | 62 | 111 | 27 | $478 |
| Metronidazole Generic | 56 | 59 | 29 | $3,156 |
| Hydroxyzine Hcl Generic | 48 | 67 | 18 | $412 |
| Spironolactone Generic | 47 | 65 | 14 | $163 |
| Dupixent Pen Dupilumab | 43 | 43 | Under 11 | $166K |
| Fluocinonide Generic | 37 | 41 | 24 | $1,010 |
| Hydrocortisone Generic | 30 | 33 | 23 | $215 |
| Valacyclovir Valacyclovir Hcl | 29 | 32 | 14 | $833 |
| Methotrexate Methotrexate Sodium | 28 | 36 | 11 | $276 |
| Tretinoin Generic | 28 | 29 | 19 | $1,482 |
Brand drugs: - claims; generic drugs: 1,736 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Randy G Banks $1,091 ($1,091 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $284.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $284 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $172 |
| Janssen Biotech, Inc. JNJ | 8 | $149 |
| Genzyme Corporation SNY | 4 | $107 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $100 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $79.09 |
| Lilly USA, LLC LLY | 3 | $73.96 |
| Organogenesis Inc. ORGO | 2 | $45.13 |
| UCB, Inc. UCB.BR | 1 | $27.65 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $20.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.